Exploring the Frontier of Biopolymer-Assisted Drug Delivery: Advancements, Clinical Applications, and Future Perspectives in Cancer Nanomedicine
DOI: https://doi.org/10.2147/dddt.s441325
IF: 4.3188
2024-06-11
Drug Design Development and Therapy
Abstract:Hanan M Alharbi Department of Pharmaceutical Sciences, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia Correspondence: Hanan M Alharbi, Department of Pharmaceutics, Faculty of Pharmacy, Umm Al-Qura University, Makkah, 21955, Saudi Arabia, Email The burgeoning global mortality rates attributed to cancer have precipitated a critical reassessment of conventional therapeutic modalities, most notably chemotherapy, due to their pronounced adverse effects. This reassessment has instigated a paradigmatic shift towards nanomedicine, with a particular emphasis on the potentialities of biopolymer-assisted drug delivery systems. Biopolymers, distinguished by their impeccable biocompatibility, versatility, and intrinsic biomimetic properties, are rapidly ascending as formidable vectors within the cancer theragnostic arena. This review endeavors to meticulously dissect the avant-garde methodologies central to biopolymer-based nanomedicine, exploring their synthesis, functional mechanisms, and subsequent clinical ramifications. A key focus of this analysis is the pioneering roles and efficacies of lipid-based, polysaccharide, and composite nano-carriers in enhancing drug delivery, notably amplifying the enhanced permeation and retention effect. This examination is further enriched by referencing flagship nano formulations that have received FDA endorsement, thereby underscoring the transformative potential and clinical viability of biopolymer-based nanomedicines. Furthermore, this discourse illuminates groundbreaking advancements in the realm of photodynamic therapy and elucidates the implications of advanced imaging techniques in live models. Conclusively, this review not only synthesizes current research trajectories but also delineates visionary pathways for the integration of cutting-edge biomaterials in cancer treatment. It charts a course for future explorations within the dynamic domain of biopolymer-nanomedicine, thereby contributing to a deeper understanding and enhanced application of these novel therapeutic strategies. Keywords: theragnostic, nanomedicines, antitumor, drug delivery, nanotherapeutic, anticancer, biopolymers The meteoric rise of cancer as a dominant driver of global mortality underscores the urgent need for action in healthcare initiatives and scientific inquiry. Predictions forewarned of a staggering 10 million cancer-related fatalities in 2020 alone, with the World Health Organization suggesting a potential tripling of this statistic by 2040. 1–3 Most strikingly, 70% of these fatalities occur in low- to middle-income nations, mirroring shifts in lifestyle paradigms. Contemporary cancer interventions, such as chemotherapy, surgery, radiation, immunotherapy, and hormone therapy, are associated with a gamut of side effects. 4–6 The notorious side effects of chemotherapy, ranging from myelotoxicity to cardiotoxicity, stem from non-specific delivery and the amplification of unintended cellular damage. 7–11 This provides a clear indication of the pressing need for precision-focused anticancer drugs. Within this backdrop, nanomedicine has emerged not merely as an alternative, but also as a transformative vector in pharmaceutical research, especially within the drug delivery spectrum. 10–14 Nanomaterials are revolutionizing cancer therapy by offering novel and more effective treatment options. Their unique properties, such as small size, large surface area-to-volume ratio, and the ability to engineer their surface for specific targeting, make them ideal candidates for cancer treatment applications. Nanomaterials are used in various forms, including nanoparticles, nanoshells, and quantum dots, each serving distinct purposes in cancer therapy. For instance, they are employed to deliver drugs directly to tumor cells, significantly reducing the side effects associated with traditional chemotherapy by minimizing drug exposure to healthy cells. Additionally, nanomaterials are utilized in thermal therapy, where they are engineered to absorb specific wavelengths of light, heating up and destroying cancer cells with minimal damage to surrounding tissues. They also play a crucial role in diagnostic applications, enhancing the sensitivity and specificity of cancer detection methods through improved imaging techniques. Furthermore, the integration of diagnostic and therapeutic functions, known as theranostics, exemplifies a significant advancement in personalized medicine, allowing for targeted cancer treatment based on real-time monitoring of the tumor environment. Overall, the application of nanomaterials in cancer therapy holds great promise for improving treatment outcomes, reducing side effects, and paving the way for more personalized and efficient cancer care. 1,15 Biopolymers, with particle sizes ranging from 10 to 1000 nm, have b -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal